Skip to main content
PMC home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1972;46(2):151–157.

Field trial with human and equine influenza vaccines in children: protection and antibody titres

A Wesselius-de Casparis, N Masurel, K F Kerrebijn
PMCID: PMC2480703  PMID: 4555773

Abstract

A placebo-controlled influenza vaccination trial was carried out on 374 children in the winter of 1967-68. The children were randomly vaccinated with 300 CCA of A2/England/1/1966, 300 CCA of A/equine 2/Miami/1963, or with a placebo. During this winter an influenza outbreak occurred, caused by A2/Nederland/1968. The A2 vaccine yielded a protection rate of 58% (P = 0.02) and the A/equine 2 vaccine a rate of 19% (P = 0.33). Serological data revealed that all influenza infections occurred in subjects who had a pre-epidemic haemagglutination inhibition titre below 150. The antibody response against various human influenza A2 viruses and against the horse strain (A/equine 2) is discussed.

Full text

PDF
157

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DAVENPORT F. M., HENNESSY A. V. The clinical epidemiology of Asian influenza. Ann Intern Med. 1958 Sep;49(3):493–501. doi: 10.7326/0003-4819-49-3-493. [DOI] [PubMed] [Google Scholar]
  2. DAVOLI R., CORSI O. B. Anticorpi verso virus dell'influenza A-Asia nella poplazione normale. Sperimentale. 1957 Sep-Oct;107(5):358–362. [PubMed] [Google Scholar]
  3. KASEL J. A., ALFORD R. H., KNIGHT V., WADDELL G. H., SIGEL M. M. EXPERIMENTAL INFECTION OF HUMAN VOLUNTEERS WITH EQUINE INFLUENZA VIRUS. Nature. 1965 Apr 3;206:41–43. doi: 10.1038/206041a0. [DOI] [PubMed] [Google Scholar]
  4. MULDER J., MASUREL N. Pre-epidemic antibody against 1957 strain of Asiatic influenza in serum of older people living in the Netherlands. Lancet. 1958 Apr 19;1(7025):810–814. doi: 10.1016/s0140-6736(58)91738-0. [DOI] [PubMed] [Google Scholar]
  5. Masurel N. Antibody response obtained by vaccination with the influenza A-Equi 2 virus in man. Nature. 1968 Apr 6;218(5136):100–101. doi: 10.1038/218100a0. [DOI] [PubMed] [Google Scholar]
  6. Masurel N. Een nieuwe verschijningsvorm van het influenza-A-virus. Ned Tijdschr Geneeskd. 1968 Oct 19;112(42):1930–1932. [PubMed] [Google Scholar]
  7. Masurel N. Het influenza-A-virus als verwekker van pandemieën en epidemieën. Ned Tijdschr Geneeskd. 1967 Jul 15;111(28):1245–1247. [PubMed] [Google Scholar]
  8. Masurel N., Mulder J. Studies on the content of antibodies for equine influenza viruses in human sera. Bull World Health Organ. 1966;34(6):885–893. [PMC free article] [PubMed] [Google Scholar]
  9. Masurel N. Relation between Hong Kong virus and former human A2 isolates and the A-EQU12 virus in human sera collected before 1957. Lancet. 1969 May 3;1(7601):907–910. doi: 10.1016/s0140-6736(69)92544-6. [DOI] [PubMed] [Google Scholar]
  10. Masurel N. Serological characteristics of a "new" serotype of influenza A virus: the Hong Kong strain. Bull World Health Organ. 1969;41(3):461–468. [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES